Open company graph database — free web & API
Login

CellPro Japan Corporation

セルプロジャパン株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
3
§01

Basic information

BASIC
Head office
Kanagawa Prefecture, Fujisawa City, Muraoka Higashi 2-chome, 26-1
Chief executive
Fumihira Samata
Capital
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

3
Regenerative Medicine BusinessAnalysis and Processing Contract BusinessCosmetics and Raw Material Business
§04

Related companies

3 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Mizuho Bank, Ltd.
Bank
Resona Bank Co., Ltd.
Bank
Sumitomo Mitsui Banking Corporation
Bank
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

5 EVENTS

CellPro Japan Corporation EstablishmentSources

Capital increase to 5.5 million yenSources

Capital increase to 45.5 million yenSources

Acquired Cosmetics Manufacturing and Sales License (License Number: 14C0X10172)Sources

Acquired Pharmaceutical Wholesale License (License Number: 030032)Sources

§07

News

16 ARTICLES

Cellpro Japan’s Medicacell Sells Out on QVC for the Third TimeSources

Cellpro Japan Inc. announced that Medicacell HA Serum sold out for the third consecutive time, following QVC broadcasts in May, August, and September. CEO Bunpei Samata expressed gratitude for the product’s success in retail sales.

Medicacell HA Stem Serum Sells Out Again on QVCSources

Medicacell HA Stem Serum sold out again after strong demand on shopping channel QVC. Although inventory was about twice the previous amount, orders surged during the early-morning broadcast and all stock sold out while it was on air. The president and CEO commented that the product is attracting attention in regenerative beauty.

Patent Granted for Cell Culture and Culture Supernatant Production MethodsSources

Cellpro Japan Inc. obtained a domestic patent for a new method of producing human stem cell-derived culture supernatant. The method raises glucose levels in the basal medium to improve cell proliferation and the concentration of beneficial components, addressing low cell viability and growth with conventional media. A PCT international application was filed in October 2023, and overseas expansion is under consideration.

Medicacell HA Stem Serum Sells Out Shortly After QVC LaunchSources

Cellpro Japan Inc. launched Medicacell HA Stem Serum on QVC on May 14, 2025, and it sold out about 11 minutes after the broadcast began. The serum contains 50% human amniotic membrane-derived stem cell conditioned culture medium and is primarily marketed to beauty clinics and salons. The company is considering another QVC sale, new sales channels, and development of related products.

CEO Bunpei Samata to Speak at Expo 2025 Osaka, KansaiSources

Bunpei Samata is scheduled to give a special invited lecture at the Future Life Village at Expo 2025 Osaka, Kansai. The lecture will cover medicine and healthcare, including regenerative medicine using growth factors in blood.

Cellpro Japan to Expand Blood Processing CenterSources

Cellpro Japan will expand its blood processing center in Ota-ku, Tokyo, to meet growing demand for contract blood-derived processing services. Since the service launched in 2022, the number of partner medical institutions and contract cases has grown, and the company plans to introduce new technologies.

Bunpei Samata to Speak at the 113th Annual Meeting of the Japan Society of Aesthetic SurgerySources

Cellpro Japan Inc. President and CEO Bunpei Samata will take part in a panel discussion at the Japan Society of Aesthetic Surgery meeting on May 29, 2025. The panel will discuss collaboration between regenerative and aesthetic medicine, the current landscape, and future challenges.

Cellpro Japan Obtains Pharmaceutical Wholesaler LicenseSources

Cellpro Japan has obtained a license to sell pharmaceuticals wholesale. In addition to its existing product lineup, it can now handle other pharmaceuticals. The company plans to expand its business to meet the needs of medical institutions.

Cellpro Japan Announces Patent Application for New TechnologySources

Cellpro Japan has completed a patent application for new technology related to its PDF-FD blood processing service. The technology raises growth factor concentrations to about 20 times the conventional level while maintaining safety, increasing the concentration of blood components. It aims to address treatment needs such as knee joint conditions in older adults.

Cellpro Japan President Elected as Councilor of the Japanese Society for Regenerative MedicineSources

Fumihira Samata, president and representative director of Cellpro Japan Co., Ltd., was elected as a councilor of the Japanese Society for Regenerative Medicine, a general incorporated association. The society promotes progress in regenerative medicine through research and policy recommendations. Mr. Samata plans to deepen understanding of regenerative medicine’s role in society and contribute to research and its application for public benefit.

§08

Public records

GOV
National Tax Agency basic information5021001067195
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
セルプロジャパン株式会社
Trade name (kana)
セルプロジャパン
Name in English
Corporation type
301
Address
〒251-0012 神奈川県藤沢市村岡東2丁目26番地の1
Postal code
2510012
Prefecture code
14
City code
205
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2019-05-13
Update date
2019-05-16
Change date
2019-05-13
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
0
Trade name image ID
Address image ID
Sequence number
2803631
METI gBizINFO5021001067195
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
5021001067195
Trade name
セルプロジャパン株式会社
Trade name (kana)
セルプロジャパン
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
神奈川県藤沢市村岡東2丁目26番地の1
Postal code
2510012
Prefecture
神奈川県
Prefecture code
14
City or district
藤沢市
City code
205
Street address
村岡東2丁目26番地の1
Organisation type
301
Processing type
01
Correction type
0
Status
Representative
Capital
Employees
29
Employees (male)
12
Employees (female)
17
Business summary
Website URL
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2019-05-16
Key information
5021001067195
§09

Sources & updates

SOURCES
↑